Literature DB >> 116685

The effects of platinum complexes on seven enzymes.

J L Aull, R L Allen, A R Bapat, H H Daron, M E Friedman, J F Wilson.   

Abstract

The effects of K2PtCl4, cis-Pt(NH3)2Cl2, and trans-Pt(NH3)2Cl2 on the activities of glyceraldehyde-3-phosphate dehydrogenase, glucose-6-phosphate dehydrogenase, dihydrofolate reductase, fructose-1,6-bisphosphate aldolase, catalase, tyrosinase, and peroxidase have been investigated. All of the enzymes which are thought to have essential sulfhydryl groups (glyceraldehyde-3-phosphate dehydrogenase, aldolase, and glucose-6-phosphate dehydrogenase) were significantly inhibited by K2PtCl4. The other four enzymes studied are not known to have essential sulfhydryl groups, and were not significantly affected by the Pt compounds under the conditions employed. Glyceraldehyde-3-phosphate dehydrogenase was the only enzyme inhibited by all three Pt compounds tested, with K2PtCl4 being the most effective and cis-Pt(NH3)2Cl2 the least effective inhibitor. Semilogarithmic plots of residual activity versus inhibition time indicated that the inhibition reactions were not simple first-order processes, except for the inhibition of glucose-6-phosphate dehydrogenase by K2PtCl4 which appeared to be first-order with respect to enzyme concentration.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 116685     DOI: 10.1016/0005-2744(79)90105-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Modification of methyliminodiacetato-trans-R,R-1,2-diamminocyclohexane platinum(II) pharmacology using a platinum-specific monoclonal antibody.

Authors:  M G Rosenblum; J L Murray; S Stuckey; R A Newman; S Chaney; A R Khokhar
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Modification of the tandem reactive centres of human inter-alpha-trypsin inhibitor with butanedione and cis-dichlorodiammineplatinum(II).

Authors:  M W Swaim; S V Pizzo
Journal:  Biochem J       Date:  1988-08-15       Impact factor: 3.857

Review 3.  Antitumor activity of platinum complexes.

Authors:  J Drobník
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

Review 4.  Cisplatinum: a review, with special reference to cellular and molecular interactions.

Authors:  C L Litterst
Journal:  Agents Actions       Date:  1984-12

5.  Alterations in hepatic and renal levels of glutathione and activities of glutathione S-transferase from rats treated with cis-dichlorodiammineplatinum-II.

Authors:  C L Litterst; S Tong; Y Hirokata; Z H Siddik
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

6.  Effects of cis-diamminedichloroplatinum (CDDP) on HeLa cell non-histone nuclear proteins.

Authors:  M Nazimiec; S T Crooke; A W Prestayko
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.